Cargando…
Use of V-Go(®) Insulin Delivery Device in Patients with Sub-optimally Controlled Diabetes Mellitus: A Retrospective Analysis from a Large Specialized Diabetes System
INTRODUCTION: Tight glycemic control and timely treatment can improve outcomes in patients with diabetes yet many remain sub-optimally controlled. The objective of the current study was to evaluate the effect of switching patients with sub-optimally controlled diabetes to the V-Go(®) (Valeritas Inc....
Autores principales: | Lajara, Rosemarie, Fetchick, Dianne A., Morris, Tracy L., Nikkel, Carla |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4674471/ https://www.ncbi.nlm.nih.gov/pubmed/26470692 http://dx.doi.org/10.1007/s13300-015-0138-7 |
Ejemplares similares
-
The Clinical and Economic Impact of the V-Go(®) Disposable Insulin Delivery Device for Insulin Delivery in Patients with Poorly Controlled Diabetes at High Risk
por: Lajara, Rosemarie, et al.
Publicado: (2016) -
Clinical Benefits Over Time Associated with Use of V-Go Wearable Insulin Delivery Device in Adult Patients with Diabetes: A Retrospective Analysis
por: Sutton, David, et al.
Publicado: (2018) -
Clinical Evaluation of Basal-Bolus Therapy Delivered by the V-Go(®) Wearable Insulin Delivery Device in Patients with Type 2 Diabetes: A Retrospective Analysis
por: Zeidan, Trisha, et al.
Publicado: (2020) -
Multicenter Real-World Assessment of the Effectiveness of V-Go Wearable Insulin Delivery Device in Adult Patients with Type 2 Diabetes (ENABLE Study): A Retrospective Analysis
por: Hundal, Ripu, et al.
Publicado: (2020) -
Efficacy, safety and cost-effectiveness comparison between U-100 human regular insulin and rapid acting insulin when delivered by V-Go wearable insulin delivery device in type 2 diabetes
por: Mora, Pablo F, et al.
Publicado: (2020)